Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Regular Articles

Infection with Oncolytic Herpes Simplex Virus-1 Induces Apoptosis in Neighboring Human Cancer Cells

A Potential Target to Increase Anticancer Activity

Stephen F. Stanziale, Henrik Petrowsky, Prasad S. Adusumilli, Leah Ben-Porat, Mithat Gonen and Yuman Fong
Stephen F. Stanziale
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Petrowsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasad S. Adusumilli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah Ben-Porat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mithat Gonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuman Fong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-1083-3 Published May 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    NV1066 induces apoptosis in infected cells as demonstrated by nuclear staining (A–C) and terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL; D–F). OCUM cells were infected with NV1066 (MOI = 0.1) and examined under separate filters for GFP expression and apoptosis. Representative fields are depicted here and quantitatively described in Table 1<$REFLINK> . A, infected cells stained with Hoechst DNA fluorochrome express enhanced green fluorescent protein (eGFP) as seen under a GFP filter at ×630 magnification. The eGFP protein can be found within nuclei and cytoplasm. B, under a 4′,6-diamidino-2-phenylindole filter, Hoechst staining illustrates high resolution of nuclear morphology to assess nuclear morphology. C, an overlay image is created by superimposing the GFP and 4′,6-diamidino-2-phenylindole filter images to concurrently evaluate nuclear morphology and eGFP expression. Characteristic morphology of apoptotic cells, including pyknosis, nuclear fragmentation, and apoptotic bodies, is seen in the cells at the white arrows. These cells do not express eGFP; that is, they are apoptotic but are not infected. The inset taken from another field illustrates that an apoptotic cell can express eGFP. Characteristic apoptotic bodies are shown within the eGFP-filled cytoplasm. D, infected cells are stained by TUNEL and examined under a GFP filter at ×945 magnification. Expression of eGFP represents viral infection. E, using phase-contrast, bright-field microscopy, TUNEL staining is evaluated. Several apoptotic cells are depicted by brown-stained nuclei. F, an overlay image is created to compare TUNEL positivity and eGFP expression. TUNEL-positive cells do not express eGFP, confirming that apoptosis occurs in noninfected cells.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Inhibition of apoptosis increases expression of the viral eGFP gene. Cells were infected with NV1066 at a multiplicity of infection (MOI) of 0.1 and a MOI of 0.01 and exposed to 10 mm N-acetylcysteine (NAC) or 1 mm NAC or left untreated. Cells were harvested and examined by flow cytometry for enhanced green fluorescent protein expression each day for 4 days after infection. Inhibition of apoptosis with NAC increases enhanced green fluorescent protein expression at both MOIs when compared with infection alone in this representative experiment (P < 0.001, z-test).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Inhibition of apoptosis increases viral cytotoxicity and proliferation. OCUM cells are infected in vitro at multiplicities of infection of 0.1 and 0.01 and treated or not treated with 10 mm N-acetylcysteine (NAC). All samples were performed in triplicate and are presented as the mean ± SE. A, cells were harvested every day for a week, and cell survival was determined in a lactate dehydrogenase release assay. Cytotoxicity of viral treatment is enhanced in the presence of NAC at all time points until maximal lysis is achieved. B, supernatants from cell cultures were assayed in a standard viral plaque assay for viral count. By day 4, there is an increase of approximately 3× and 19× in viral production in the presence of NAC in the multiplicity of infection = 0.1 and 0.01 cultures, respectively.

Tables

  • Figures
  • Table 1

    NV1066 induces apoptosis in uninfected and infected cells

    Random microscopic fields of NV1066-treated cells were assessed for nuclear morphology and eGFP expression, counted, and averaged from three experiments. Cells are either apoptotic and do not express eGFP, not apoptotic and express eGFP, apoptotic and express eGFP, or not apoptotic and do not express eGFP. The last group is not represented in the table. There was a significantly higher rate of apoptosis in the infected cells compared with uninfected cells (P < 0.005, Fisher’s exact test). Untreated samples represent the spontaneous rate of apoptosis in cultured cells. Actinomycin D was used as a positive control for the induction of apoptosis.

    Cell phenotype (%)
    A+/G−aA−/G+A+/G+
    Untreated0.8 ± 0.1b0.1 ± 0.10.0 ± 0.0
    MOI of 0.19.6 ± 2.8b12.8 ± 2.44.4 ± 1.9
    Actinomycin D (1.2 μm)18.4 ± 4.70.0 ± 0.00.0 ± 0.0
    • a A, apoptotic; G, enhanced green fluorescent protein; MOI, multiplicity of infection.

    • b P = 0.009.

PreviousNext
Back to top
Clinical Cancer Research: 10 (9)
May 2004
Volume 10, Issue 9
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Infection with Oncolytic Herpes Simplex Virus-1 Induces Apoptosis in Neighboring Human Cancer Cells
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Infection with Oncolytic Herpes Simplex Virus-1 Induces Apoptosis in Neighboring Human Cancer Cells
Stephen F. Stanziale, Henrik Petrowsky, Prasad S. Adusumilli, Leah Ben-Porat, Mithat Gonen and Yuman Fong
Clin Cancer Res May 1 2004 (10) (9) 3225-3232; DOI: 10.1158/1078-0432.CCR-1083-3

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Infection with Oncolytic Herpes Simplex Virus-1 Induces Apoptosis in Neighboring Human Cancer Cells
Stephen F. Stanziale, Henrik Petrowsky, Prasad S. Adusumilli, Leah Ben-Porat, Mithat Gonen and Yuman Fong
Clin Cancer Res May 1 2004 (10) (9) 3225-3232; DOI: 10.1158/1078-0432.CCR-1083-3
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Regular Articles

  • Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in Mice
  • Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
  • Combination Antiangiogenic and Androgen Deprivation Therapy for Prostate Cancer
Show more Regular Articles

Experimental Therapeutics, Preclinical Pharmacology

  • Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in Mice
  • Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
  • Combination Antiangiogenic and Androgen Deprivation Therapy for Prostate Cancer
Show more Experimental Therapeutics, Preclinical Pharmacology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement